Daniéla Rusu

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer

Sophie Leboulleux, Claire Bournaud, C. Chougnet et al. · New England Journal of Medicine · 2022 · 212 citations · Full text

Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial

Martin Schlumberger, Sophie Leboulleux, Bogdan Catargi et al. · The Lancet Diabetes & Endocrinology · 2018 · 158 citations

Cancer Management, Thyroid Disease, Low-risk Thyroid Cancer +6

Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial

Isabelle Borget, Julia Bonastre, Bogdan Catargi et al. · Journal of Clinical Oncology · 2015 · 95 citations · Full text

Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial

Sophie Leboulleux, Claire Bournaud, C. Chougnet et al. · The Lancet Diabetes & Endocrinology · 2024 · 29 citations · Full text

Preliminary results of a ⁶⁸Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making

Caroline Rousseau, Maëlle Le Thiec, Ludovic Ferrer et al. · The Prostate · 2019 · 27 citations · Full text